Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Capital Employed (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Return on Capital Employed for 7 consecutive years, with 0.02% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 1.0% to 0.02% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.02% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.02% for FY2025, 0.0% changed from the prior year.
  • Return on Capital Employed hit 0.02% in Q4 2025 for Eton Pharmaceuticals, down from 0.01% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.39% in Q3 2023 to a low of 0.57% in Q2 2022.
  • Historically, Return on Capital Employed has averaged 0.16% across 5 years, with a median of 0.07% in 2021.
  • Biggest five-year swings in Return on Capital Employed: surged 184bps in 2021 and later crashed -81bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.07% in 2021, then tumbled by -69bps to 0.11% in 2022, then soared by 31bps to 0.08% in 2023, then surged by 71bps to 0.02% in 2024, then grew by 28bps to 0.02% in 2025.
  • Business Quant data shows Return on Capital Employed for ETON at 0.02% in Q4 2025, 0.01% in Q3 2025, and 0.02% in Q2 2025.